Cargando…
Evaluation of the Utilization Patterns of Leukotriene Modifiers in a Large Managed Care Health Plan
OBJECTIVES: To assess the utilization of leukotriene modifiers (LM) relative to national guidelines and to investigate possible emergency room utilization differences for LMs as monotherapy versus inhaled corticosteroid (ICS) monotherapy or combination ICS and LM therapy. METHODS: The utilization of...
Autores principales: | Lakomski, Paul G., Chitre, Mona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437895/ https://www.ncbi.nlm.nih.gov/pubmed/15032560 http://dx.doi.org/10.18553/jmcp.2004.10.2.115 |
Ejemplares similares
-
Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010) -
Leukotrienes as Modifiers of Preclinical Atherosclerosis?
por: Riccioni, Graziano, et al.
Publicado: (2012) -
3-Year Results of a Member and Physician Intervention to Reduce Risk Associated With Glucocorticoid-Induced Osteoporosis in a Health Plan
por: Chitre, Mona M., et al.
Publicado: (2008) -
Genome-wide association study of leukotriene modifier response in asthma
por: Dahlin, A, et al.
Publicado: (2016) -
Angioedema suppressed by a combination of anti-histamine and leukotriene modifier
por: Wong, Brendan N., et al.
Publicado: (2017)